Please login to the form below

Not currently logged in
Email:
Password:

cardiology

This page shows the latest cardiology news and features for those working in and with pharma, biotech and healthcare.

TMC preps filings for inclisiran after final phase 3 trials hit the mark

TMC preps filings for inclisiran after final phase 3 trials hit the mark

Society of Cardiology (ESC) congress earlier this month.

Latest news

More from news
Approximately 8 fully matching, plus 148 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest appointments

  • New faces at W2O, 90TEN and Porterhouse New faces at W2O, 90TEN and Porterhouse

    During her career, Baccari has lead high-profile global initiatives across various therapy areas including neurology, oncology and cardiology.

  • emotive bolsters client services team emotive bolsters client services team

    During her six years at Chameleon, she was responsible for medical communications acitivites in various therapy areas including diabetes, cardiology, immunology, gastroenterology and rare diseases.

  • Axon bolsters team with new PR Director hire Axon bolsters team with new PR Director hire

    During her career, Smiddy has led local, regional and international programmes to support pharmaceutical products in numerous therapeutic fields including cardiology, immunology, CNS and oncology.

  • Former Novartis vaccines CMO joins Arterial Former Novartis vaccines CMO joins Arterial

    board. Dr Weissback brings over 25 years of life science industry experience to the post - with particular expertise in cardiology, infectious diseases and oncology - and is currently chief operating officer at

  • MyoKardia appoints COO and medical affairs VP MyoKardia appoints COO and medical affairs VP

    Dr Lee (pictured right) joins the cardiology specialist from the University of California, San Francisco (UCSF), where she was director of the therapeutics and digital health technologies accelerator programme, Catalyst, at

More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

  • Wilmington Healthcare appoints new consultants

    He has joined Wilmington Healthcare from Bristol-Myers Squibb, where he was Senior Regional Access Manager and led new customer- focused initiatives for the company in cardiology and oncology.

  • Programmatic methodology and why you should be using it

    HCPs. This means that if we wanted to target cardiologists for example, we don’t have to just target through cardiology journals or publications, but we can reach the required users

  • 90TEN appoints May Baccari to senior management team

    May’s 18-year career has seen her leading high-profile global initiatives across various therapy areas including neurology, oncology and cardiology, as well as internal change programmes. ... May’s career has seen her leading high-profile global

  • Conference research case study

    Communication strategies and marketing messages were to be crafted using the outcomes data which our client planned to launch at the European Society of Cardiology (ESC) annual congress.

  • Bringing the NHS into the 21st century

    We have consultants specialising in cardiology, endocrine, ENT, gynaecology, haematology, neurology, respiratory, orthopaedics, rheumatology, and urology.

More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Eye for Pharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics